Recommended

New webinar: Overcoming critical challenges in AI-driven drug discovery

Watch on demand: Rapid cell-based profiling of multi-target anti-obesity drugs Watch here!

Download now: Unlock the power of stem cell therapy and discover the potential for new therapies for primary open-angle glaucoma

Brand new Beyond the Lab report on antibodies… Download NOW!

List view / Grid view

News

arGEN-X announces publication on therapeutic potential of ARGX-115 in cancer immunotherapy

24 April 2015 | By Victoria White

arGEN-X and de Duve Institute/UCL/WELBIO have announced the publication of new data showing that ARGX-115 blocks the activity of GARP...

AstraZeneca and Celgene collaborate to develop MEDI4736 for patients with serious blood cancers

24 April 2015 | By Victoria White

AstraZeneca and Celgene collaborate for the development and commercialisation of MEDI4736 across a range of blood cancers, including non-Hodgkin’s lymphoma...

Preclinical data demonstrates BLU-554 induces significant tumour regression in models of hepatocellular carcinoma

24 April 2015 | By Victoria White

New preclinical data demonstrates that BLU-554 has significant anti-tumour activity in models of HCC that are dependent on FGFR4 signalling...

MRC Technology collaborates with NYU School of Medicine to develop biologics for inflammatory osteolysis

23 April 2015 | By Victoria White

MRC Technology and NYU School of Medicine have signed an agreement to develop an antibody for the prevention of inflammatory osteolysis (bone breakdown)...

Chuvash polycythemia

Chuvash polycythemia

International consortium CANCER-ID to develop novel biomarker technologies in cancer

23 April 2015 | By Victoria White

Bayer and UKE are the main coordinators of a new international consortium, CANCER-ID, to develop novel blood-based biomarker technologies in cancer...

Preclinical and mechanistic data supports use of Cytori cell therapy in wounds combining thermal burn and radiation exposure

23 April 2015 | By Victoria White

Cytori Therapeutics presented data from two preclinical studies at ABA2015. The findings provide greater detail on Cytori's cell therapies...

Dimension Therapeutics to develop gene therapy treatments for patients with Ornithine Transcarbamylase deficiency and Glycogen Storage Disease Type Ia

23 April 2015 | By Victoria White

Dimension Therapeutics is advancing programmes to treat two rare diseases with often devastating outcomes for patients - OTC deficiency and GSDIa...

New research describes blueprint for truly personalised cancer immunotherapies

23 April 2015 | By Victoria White

An article describing an important scientific foundation for the clinical development of truly personalised cancer immunotherapies has been published...

ImmuneXcite presents new preclinical data on its mAbXcite platform

22 April 2015 | By Victoria White

New preclinical data demonstrates that mAbXcite therapies causes an immune cascade that successfully recruits T-cells to mount an attack against cancer...

BTP-114

BTP-114

Blend presents preclinical data for BTP-114 that demonstrates superiority to cisplatin in tumour growth inhibition

22 April 2015 | By Victoria White

Blend Therapeutics has presented preclinical data on it's lead product candidate, BTP-114, a novel personalised cisplatin prodrug, at AACR 2015...

lung-cancer-cells

lung-cancer-cells

ARIAD announces results of preclinical studies on brigatinib at AACR 2015

22 April 2015 | By Victoria White

ARIAD has announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib (AP26113), at AACR 2015...

Astellas and Potenza enter R&D collaboration for immuno-oncology therapeutics

22 April 2015 | By Victoria White

Astellas and Potenza have entered an exclusive R&D collaboration. The agreement includes an option for the future acquisition of Potenza by Astellas...

Epizyme presents preclinical research on CARM1 and PRMT6

21 April 2015 | By Victoria White

Epizyme has presented data on two epigenetic targets, CARM1 and PRMT6, in its pioneering therapeutic pipeline at the AACR Annual Meeting 2015...

Trial shows benefit of ‘BRCA-targeting’ drug, olaparib, in prostate cancer

21 April 2015 | By Victoria White

Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...

MaxCyte and Johns Hopkins University announce strategic collaboration to advance CAR T-cell therapies

21 April 2015 | By Victoria White

MaxCyte and Johns Hopkins University to collaborate to develop unique CAR T-cell therapies which harness patients’ own immune systems to combat cancers...

Page 416 of 440
<
1
...
411
412
413
414
415
416
417
418
419
420
...
440
>

© Russell Publishing Limited, 2010-2025. All rights reserved. Terms & Conditions | Privacy Policy | Cookie Policy

Website development by e-Motive Media Limited.

<iframe src="https://www.googletagmanager.com/ns.html?id=GTM-KM6ZDN2" height="0" width="0"></iframe>

Cookie Settings

This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorised as "Necessary" are stored on your browser as they are as essential for the working of basic functionalities of the website. For our other types of cookies "Advertising & Targeting", "Analytics" and "Performance", these help us analyse and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these different types of cookies. But opting out of some of these cookies may have an effect on your browsing experience. You can adjust the available sliders to 'Enabled' or 'Disabled', then click 'Save and Accept'. View our Cookie Policy page.

Necessary

Necessary

Always Enabled

Necessary cookies enable the core functionality of the website, including security, network management and accessibility. These cookies do not store any personal information. You may disable these by changing your browser settings, but this may affect how the website functions.

Cookie	Type	Duration	Description
cookielawinfo-checkbox-advertising-targeting	persistent	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertising & Targeting".
cookielawinfo-checkbox-analytics	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Analytics".
cookielawinfo-checkbox-necessary	persistent	1 year	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-performance	persistent	1 year	This cookie is set by GDPR Cookie Consent WordPress Plugin. The cookie is used to remember the user consent for the cookies under the category "Performance".
PHPSESSID	session	1 year	This cookie is native to PHP applications. The cookie is used to store and identify a users' unique session ID for the purpose of managing user session on the website. The cookie is a session cookies and is deleted when all the browser windows are closed.
viewed_cookie_policy	persistent	1 year	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.
zmember_logged	session	1 year	This session cookie is served by our membership/subscription system and controls whether you are able to see content which is only available to logged in users.

Advertising & Targeting

Advertising and targeting cookies help us provide our visitors with relevant ads and marketing campaigns.

Cookie	Type	Duration	Description
advanced_ads_browser_width	persistent	1 month	This cookie is set by Advanced Ads and measures the browser width.
advanced_ads_page_impressions	persistent	2 years	This cookie is set by Advanced Ads and measures the number of previous page impressions.
advanced_ads_pro_server_info	persistent	1 month	This cookie is set by Advanced Ads and sets geo-location, user role and user capabilities. It is used by cache busting in Advanced Ads Pro when the appropriate visitor conditions are used.
advanced_ads_pro_visitor_referrer	persistent	1 year	This cookie is set by Advanced Ads and sets the referrer URL.
bscookie	persistent	2 years	This cookie is a browser ID cookie set by LinkedIn share Buttons and ad tags.
IDE	persistent	2 years	This cookie is set by Google DoubleClick and stores information about how the user uses the website and any other advertisement before visiting the website. This is used to present users with ads that are relevant to them according to the user profile.
li_sugr	persistent	3 months	This cookie is set by LinkedIn and is used for tracking.
UserMatchHistory	persistent	1 month	This cookie is set by Linkedin and is used to track visitors on multiple websites, in order to present relevant advertisement based on the visitor's preferences.
VISITOR_INFO1_LIVE	persistent	5 months	This cookie is set by YouTube. Used to track the information of the embedded YouTube videos on a website.

Analytics

Analytics cookies collect information about your use of the content, and in combination with previously collected information, are used to measure, understand, and report on your usage of this website.

Cookie	Type	Duration	Description
bcookie	persistent	2 years	This cookie is set by LinkedIn. The purpose of the cookie is to enable LinkedIn functionalities on the page.
GPS	persistent	30 minutes	This cookie is set by YouTube and registers a unique ID for tracking users based on their geographical location
lang	session	1 year	This cookie is set by LinkedIn and is used to store the language preferences of a user to serve up content in that stored language the next time user visit the website.
lidc	persistent	1 day	This cookie is set by LinkedIn and used for routing.
lissc	persistent	11 months	This cookie is set by LinkedIn share Buttons and ad tags.
vuid	persistent	2 years	We embed videos from our official Vimeo channel. When you press play, Vimeo will drop third party cookies to enable the video to play and to see how long a viewer has watched the video. This cookie does not track individuals.
wow.anonymousId	persistent	2 years	This cookie is set by Spotler and tracks an anonymous visitor ID.
wow.schedule	persistent	20 minutes	This cookie is set by Spotler and enables it to track the Load Balance Session Queue.
wow.session	persistent	20 minutes	This cookie is set by Spotler to track the Internet Information Services (IIS) session state.
wow.utmvalues	persistent	20 minutes	This cookie is set by Spotler and stores the UTM values for the session. UTM values are specific text strings that are appended to URLs that allow Communigator to track the URLs and the UTM values when they get clicked on.
_ga	persistent	2 years	This cookie is set by Google Analytics and is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. It stores information anonymously and assign a randomly generated number to identify unique visitors.
_gat	persistent	1 minute	This cookies is set by Google Universal Analytics to throttle the request rate to limit the collection of data on high traffic sites.
_gid	persistent	1 day	This cookie is set by Google Analytics and is used to store information of how visitors use a website and helps in creating an analytics report of how the website is doing. The data collected including the number visitors, the source where they have come from, and the pages visited in an anonymous form.

Performance

Performance cookies include cookies that deliver enhanced functionalities of the website, such as caching. These cookies do not store any personal information.

Cookie	Type	Duration	Description
cf_ob_info	persistent	1 minute	This cookie is set by Cloudflare content delivery network and, in conjunction with the cookie 'cf_use_ob', is used to determine whether it should continue serving “Always Online” until the cookie expires.
cf_use_ob	persistent	1 minute	This cookie is set by Cloudflare content delivery network and is used to determine whether it should continue serving “Always Online” until the cookie expires.
free_subscription_only	session	1 year	This session cookie is served by our membership/subscription system and controls which types of content you are able to access.
ls_smartpush	persistent	1 month	This cookie is set by Litespeed Server and allows the server to store settings to help improve performance of the site.
one_signal_sdk_db	persistent	Until cleared	This cookie is set by OneSignal push notifications and is used for storing user preferences in connection with their notification permission status.
YSC	session	1 year	This cookie is set by Youtube and is used to track the views of embedded videos.